Filter Results:
(63)
Show Results For
- All HBS Web
(934)
- People (2)
- News (63)
- Research (769)
- Events (1)
- Multimedia (2)
- Faculty Publications (661)
Show Results For
- All HBS Web
(934)
- People (2)
- News (63)
- Research (769)
- Events (1)
- Multimedia (2)
- Faculty Publications (661)
Page 1 of 63
Results →
Sort by
- 01 Mar 2011
- News
Fixing What Ails the Drug Industry
at the 11th HBS Health Industry Alumni Association Conference. She joined Eli Lilly CEO John Lechleiter in addressing the November 4–6 event, titled “The Future of Therapy from the Leaders Who Create It.” So what’s the cure for the ailing... View Details
- 01 Feb 2002
- News
Health Industry Alumni Convene for Conference
in the knowledge-based biotechnology industry to forge balanced partnership deals with the financially much stronger pharmaceutical industry." A panel led by HBS associate professor Jonathan West discussed... View Details
- 01 Mar 2007
- News
Daniel Vasella
sales of $37 billion. The company’s aggressive investment in research has made it an industry leader in new drug approvals. And when opportunity knocks, Vasella doesn’t hesitate to broaden Novartis’s business mix through acquisitions. He... View Details
- 15 Sep 2016
- News
Price of pharma innovation: Pro
- 26 Apr 2010
- News
Pharma's Future Depends on These Three Trends
- 01 Aug 2006
- News
Big Pharma's Prognosis
- 15 Feb 2011
- News
Who will blink in Genzyme, Sanofi price talks?
- 01 Feb 1999
- News
Too Much of a Good Thing?
years, sectors as diverse as automobiles, semiconductors, steel, textiles, consumer electronics, tires, and pharmaceuticals have been afflicted by overcapacity and some or all of its unpleasant side effects: loss of jobs, plant closings,... View Details
Keywords: Garry Emmons
- 01 Jun 2024
- News
Quantum Leap
“This is the first new kind of computer in 75 years,” says John Levy (MBA 1979), CEO of the quantum computing startup SEEQC. “And we’re building it on a chip!” Strolling through his company’s design and testing facility in Elmsford, New York, Levy looks less like a... View Details
- 01 Dec 2019
- News
Remix
community after their respective accusations against Clarence Thomas and Mike Tyson. It’s one of the factors that helps explain why women of color report sexual assault at rates far below that of white women and a major force behind Dixon’s decision to leave the View Details
- 01 Sep 2007
- News
Alfred D. Chandler Jr. Remembered
Matsushita. That volume was followed in 2005 by Shaping the Industrial Century: The Remarkable Story of the Evolution of the Modern Chemical and Pharmaceutical Industries. “Such science-based View Details
- 01 Oct 2001
- News
Guy de Chazal: Changing Focus
venture capital with Citicorp. "The industry was much, much smaller in those days," he says. "A few hundred million dollars a year, versus almost a hundred billion today." Drawing on his experience with Morgan Stanley since 1986, he... View Details
Keywords: Deborah Blagg
- 31 Jan 2014
- News
Body, Heal Thyself
for the development and exclusive use of the mRNA technology to treat cardiovascular, renal, and metabolic diseases as well as cancer. "It is one of the largest-ever initial payments in a pharmaceutical View Details
- 01 Mar 2016
- News
Off Script
according to one study—and the limited lifespan of patent rights. What can the pharmaceutical industry and government regulators do to improve conditions? We put your queries to Fred Hassan (MBA 1972), a... View Details
- 01 Sep 2006
- News
Gift of Gab
then delivered a prepared talk on a topic of their choice. Subjects ranged from the pharmaceutical industry to the relative merits of cats vs. dogs, while Kim’s presentation took a humorous yet thoughtful... View Details
- 01 Feb 2002
- News
Telling the Electronic Century's Unfinished Story
and pharmaceutical industries. But the differences between those pairs of sectors were just too great. So the second book will examine this question: Why were the Japanese chemical and pharmaceutical View Details
- 01 Feb 2001
- News
Drilling Down
The news last October of Chevron's proposed acquisition of Texaco for $36 billion in stock was hardly surprising to industry analysts. The planned merger — which would streamline projects and save some $1.2 billion annually — was... View Details